Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs

Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors

NCT03596593 ·Status: UNKNOWN ·Phase: NA

Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

NCT02215928 ·Status: RECRUITING

Molecular Screening for Cancer Treatment Optimization

NCT01566019 ·Status: UNKNOWN ·Phase: NA

Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients

NCT02706652 ·Status: TERMINATED

Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers

NCT06958224 ·Status: NOT_YET_RECRUITING ·Phase: NA

Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom

NCT00758056 ·Status: UNKNOWN

Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate

NCT01209299 ·Status: COMPLETED

Molecular and Genomic Profiling of Head and Neck Tumors

NCT00200486 ·Status: RECRUITING

Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom

NCT00758173 ·Status: UNKNOWN

Biomarker Research for Personalized Medicine

NCT01488591 ·Status: UNKNOWN

The Registration Program of BRCA1/2 Gene

NCT02593435 ·Status: UNKNOWN

Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer

NCT05285579 ·Status: UNKNOWN

Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection

NCT05585684 ·Status: RECRUITING

Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

NCT06851975 ·Status: RECRUITING ·Phase: NA

STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers

NCT06861621 ·Status: RECRUITING

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

NCT01703585 ·Status: COMPLETED

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

NCT01598597 ·Status: COMPLETED

Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia

NCT01079507 ·Status: UNKNOWN

Development and Application of Patient-Derived Models of Cancer

NCT07226180 ·Status: ENROLLING_BY_INVITATION

Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy

NCT05583422 ·Status: COMPLETED

GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers

NCT06076070 ·Status: UNKNOWN

Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.

NCT05083494 ·Status: UNKNOWN

Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.

NCT06929910 ·Status: RECRUITING

Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation

NCT02664389 ·Status: TERMINATED ·Phase: NA

Integrated Molecular Profiling in Advanced Cancers Trial

NCT01505400 ·Status: ACTIVE_NOT_RECRUITING